Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$21,519,655
-$5,780,777 QoQ
Shares Held
48,192
-20.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$11,635,680
PutShares
24,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026NATIXIS holds $79,787,364 across 30 Biotechnology names. VRTX ranks #2 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,307 | $42,732,400 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
48,192 | $21,519,655 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,076 | $5,649,936 | |
| 4 | ERAS |
Erasca, Inc.
|
163,192 | $2,640,446 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
81,754 | $1,712,746 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
41,536 | $1,598,720 | |
| 7 | CAI |
Caris Life Sciences, Inc.
|
52,778 | $943,670 | |
| 8 | TECH |
BIO-TECHNE Corp
|
11,286 | $589,806 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,519,655 | 48,192 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $27,300,432 | 60,218 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,673,221 | 29,806 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,783,837 | 30,961 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $26,875,511 | 55,434 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $11,635,680 | 24,000 | Put | Sole | 2025-07-18 | |
| 2024-12-31 | $9,206,527 | 22,862 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,080,993 | 36,727 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,779,295 | 44,332 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $18,659,130 | 44,638 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $21,120,032 | 51,906 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $63,000,751 | 181,172 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $32,195,190 | 91,487 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,513,725 | 17,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,662,876 | 78,478 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $6,741,938 | 23,285 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,162,965 | 32,517 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,382,097 | 5,296 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,484,890 | 20,423 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,933,534 | 187,075 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $12,895,763 | 60,011 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $13,655,252 | 57,778 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,512,062 | 20,256 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,694,258 | 23,059 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,270,756 | 9,543 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||